Innovax-ND-ILT Unión Europea - español - EMA (European Medicines Agency)

innovax-nd-ilt

intervet international b.v. - cell-associated live recombinant turkey herpesvirus (strain hvt/ndv/ilt) expressing the fusion protein of newcastle disease virus and the glycoproteins gd and gi of infectious laryngotracheitis virus - inmunológicos para aves - embryonated chicken eggs; chicken - for active immunisation of one-day-old chicks or embryonated chicken eggs:to reduce mortality and clinical signs caused by newcastle disease (nd) virus,to reduce mortality, clinical signs and lesions caused by avian infectious laryngotracheitis (ilt) virus and marek’s disease (md) virus.

Innovax-ILT Unión Europea - español - EMA (European Medicines Agency)

innovax-ilt

intervet international b.v. - virus de herpes de pavo recombinante vivo asociado a células (cepa hvt / ilt-138), que expresa las glucoproteínas gd y gi del virus de la laringotraqueítis infecciosa - immunologicals para aves, las vacunas virales - pollo - para la inmunización activa de los pollitos de un día para reducir la mortalidad, signos clínicos y lesiones debido a la infección con infecciosa aviar laryngotracheitis (ilt) de virus y la enfermedad de marek (md) de virus.

Prepandemic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted) Novartis Vaccines and Diagnostics Unión Europea - español - EMA (European Medicines Agency)

prepandemic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted) novartis vaccines and diagnostics

novartis vaccines and diagnostics s.r.l. - antígenos de superficie del virus de la gripe (hemaglutinina y neuraminidasa) de la cepa a / viet nam / 1194/2004 (h5n1) - influenza, human; immunization; disease outbreaks - vacunas - inmunización activa contra el subtipo h5n1 del virus influenza a. , , this indication is based on immunogenicity data from healthy subjects from the age of 18 years onwards following administration of two doses of the vaccine containing a/vietnam/1194/2004 (h5n1)-like strain. , , prepandemic influenza vaccine (h5n1) novartis vaccines and diagnostic should be used in accordance with official recommendations.

COVID-19 Vaccine (inactivated, adjuvanted) Valneva Unión Europea - español - EMA (European Medicines Agency)

covid-19 vaccine (inactivated, adjuvanted) valneva

valneva austria gmbh - covid-19 vaccine (inactivated, adjuvanted, adsorbed) - covid-19 virus infection - vacunas - covid-19 vaccine (inactivated, adjuvanted) valneva is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 18 to 50 years of age.  the use of this vaccine should be in accordance with official recommendations.

Zoonotic Influenza Vaccine Seqirus Unión Europea - español - EMA (European Medicines Agency)

zoonotic influenza vaccine seqirus

seqirus s.r.l.  - zoonotic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted), influenza virus surface antigens (haemagglutinin and neuraminidase) of strain: a/turkey/turkey/1/05 (h5n1)-like strain (nibrg-23) - influenza a virus, h5n1 subtype - vacunas - active immunisation against h5 subtype of influenza a virus.

Vectormune FP ILT + AE Unión Europea - español - EMA (European Medicines Agency)

vectormune fp ilt + ae

ceva-phylaxia co. ltd. - live recombinant fowlpox virus expressing the membrane fusion protein and the encapsidation protein of avian infectious laryngotracheitis virus (rfp-lt) and avian encephalomyelitis virus, strain calnek 1143 (ae) - immunologicals for aves, live viral vaccines, domestic fowl - pollo - for active immunisation of chickens of 8 to 13 weeks of age in order to reduce the skin lesions due to fowlpox, to reduce the clinical signs and tracheal lesions due to avian infectious laryngotracheitis and to prevent egg production losses due to avian encephalomyelitis.

Vectormune FP ILT Unión Europea - español - EMA (European Medicines Agency)

vectormune fp ilt

ceva-phylaxia co. ltd. - recombinant fowlpox virus expressing the membrane fusion protein and the encapsidation protein of avian infectious laryngotracheitis virus, live - pollo - for active immunisation of chickens from 8 weeks of age in order to reduce the skin lesions due to fowlpox and to reduce the clinical signs and tracheal lesions due to avian infectious laryngotracheitis.

Pandemic influenza vaccine H5N1 AstraZeneca (previously Pandemic influenza vaccine H5N1 Medimmune) Unión Europea - español - EMA (European Medicines Agency)

pandemic influenza vaccine h5n1 astrazeneca (previously pandemic influenza vaccine h5n1 medimmune)

astrazeneca ab - virus de la gripe reagrupado (vivo atenuado) de la siguiente cepa: cepa a / vietnam / 1203/2004 (h5n1) - influenza, humano - vacunas - profilaxis de la influenza en una situación de pandemia declarada oficialmente en niños y adolescentes de 12 meses a menos de 18 años de edad. vacuna contra la influenza pandémica h5n1 astrazeneca debe ser utilizado de acuerdo con las directrices oficiales.

Pandemic Influenza Vaccine H5N1 Baxter AG Unión Europea - español - EMA (European Medicines Agency)

pandemic influenza vaccine h5n1 baxter ag

resilience biomanufacturing ireland limited - vacuna contra la influenza (virión completo, inactivada) que contiene el antígeno de: a / vietnam / 1203/2004 (h5n1) - influenza, human; immunization; disease outbreaks - vacunas - profilaxis de la influenza en una situación de pandemia oficialmente declarada. la vacuna contra la influenza pandémica debe usarse de acuerdo con la guía oficial.

Vaxzevria (previously COVID-19 Vaccine AstraZeneca) Unión Europea - español - EMA (European Medicines Agency)

vaxzevria (previously covid-19 vaccine astrazeneca)

astrazeneca ab - chadox1-sars-cov-2 - covid-19 virus infection - vacunas - vaxzevria is indicated for active immunisation to prevent covid 19 caused by sars cov 2, in individuals 18 years of age and older. el uso de esta vacuna debe estar en conformidad con las recomendaciones oficiales.